Your browser doesn't support javascript.
loading
Recent advances in the development of MMPIs and APNIs based on the pyrrolidine platforms.
Li, Xun; Li, Jinpei.
Afiliación
  • Li X; School of Pharmaceutical Sciences, Shandong University, Ji'nan, Shandong Province, PR China. tjulx2004@sdu.edu.cn
Mini Rev Med Chem ; 10(9): 794-805, 2010 Aug.
Article en En | MEDLINE | ID: mdl-20482497
ABSTRACT
Pyrrolidine scaffold has been widely used to design a variety of N-heterocyclic derivatives towards various targets. Amongst them, matrix metalloproteins (MMPs) and aminopeptidase N (APN) represent two kinds of important metalloproteinase targets which have been proved to be tightly related to tumor proliferation, invasion, metastasis and angiogenesis. As a result, their respective inhibitors, namely MMP inhibitors (MMPIs) and APN inhibitors (APNIs), have been systematically studied in our group for many years. Recent advances in the elucidation of MMPIs and APNIs based on the pyrrolidine platforms are briefly reviewed in this paper.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteasas / Pirrolidinas / Antígenos CD13 / Inhibidores de la Metaloproteinasa de la Matriz Idioma: En Revista: Mini Rev Med Chem Asunto de la revista: QUIMICA Año: 2010 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteasas / Pirrolidinas / Antígenos CD13 / Inhibidores de la Metaloproteinasa de la Matriz Idioma: En Revista: Mini Rev Med Chem Asunto de la revista: QUIMICA Año: 2010 Tipo del documento: Article